References
- Kunin CM. Clinical pharmacology of the new penicillins tL Effect of drugs which interfere with binding to serum proteins. Clin. Pharm. Therap. 1965; 7: 180–188
- Davison C., Smith P. K. The binding of salicyclic acid and related substances to purified proteins. J. Pharm. Exper. Therap. 1961; 133: 161–170
- Goldbaum L., Smith P. The interaction of barbiturates with serum albumin and its possible relation to their dispositions and pharmacological actions. J. Pharm. Exper. Therap. 1954; III: 197–209
- Jones F. W., Finland M. Blood levels from orally administered penicillins G and V. New Engl. J. Med. 1955; 253: 754–761
- Goodman L. S., Gillman A. The Pharmacological Basis of Therapeutics, 4th ed. Macmillan, New York 1970; 112–188
- Lieberman S. V., Kraus S. R., Murray J., Wood J. H. Aspirin formulation and absorption rate 1 criteria for serum measurements with human panels. J. Pharm. Sci. 1964; 53: 1486
- Cummings A. J., Martin B. K. Factors influencing the plasma salicylate concentration and urinary salicylate excretion after oral dosage with aspirin. Blochem. Pharmacol. 1964; 13: 767
- Bennett J. V., Klrby W. M. M. A rapid modified ultrafiltration method for determining serum protein binding and its application to new penicillin. J. Lab. & Clin. Med. 1965; 66: 721–732
- Edsall J. T., Wyman J. Biophysical Chemistry. Academic. 1958; 605–661
- Aggeler P. M., O'Reilly R. A., Leong L., Kowitz P. E. Potentiation of anticoagulant effect of warfarin by phenylbutazone. New Engl. J. Med. 1967; 276: 496–501
- Sellers E. M., Koch-Weser J. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann. N. Y. Acad. Sci. 1971; 179: 213–225
- Solomon H. M., Schrogie J. G., Williams D. The displacement of phenylbutazone-C′ and Warfarin-C14 from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 1968; 17: 143
- Meyer M. C., Guttman D. E. The binding of drugs by plasma proteins. J. Pharm. Chem. 1968; 57: 895–918